Provided by Tiger Trade Technology Pte. Ltd.

Predictive Oncology

5.92
+0.36006.47%
Volume:49.66K
Turnover:291.10K
Market Cap:20.09M
PE:-0.30
High:6.25
Open:5.34
Low:5.34
Close:5.56
52wk High:45.90
52wk Low:3.88
Shares:3.39M
Float Shares:3.07M
Volume Ratio:0.51
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-19.9822
EPS(LYR):-34.8329
ROE:-746.03%
ROA:-128.80%
PB:-0.26
PE(LYR):-0.17

Loading ...

Company Profile

Company Name:
Predictive Oncology
Exchange:
NASDAQ
Establishment Date:
2002
Employees:
24
Office Location:
91 43rd Street,Suite 110,Pittsburgh,Pennsylvania,United States
Zip Code:
15201
Fax:
- -
Introduction:
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvements, stability studies, and protein production. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.

Directors

Name
Position
Raymond F. Vennare
Chairman and Chief Executive Officer and Director
Chuck Nuzum
Director
Daniel E. Handley
Director
Gregory S. St. Clair
Director
Matthew J. Hawryluk
Director
Shawn Matthews
Director
Veena Rao
Director

Shareholders

Name
Position
Raymond F. Vennare
Chairman and Chief Executive Officer and Director
Josh Blacher
Chief Financial Officer
Thomas L. McLaughlin
Chief Investment Officer